LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
4.130
+0.040 (0.98%)
At close: Nov 13, 2026, 4:00 PM EST
4.210
+0.080 (1.94%)
After-hours: Nov 13, 2026, 7:52 PM EST
LENZ Therapeutics Employees
LENZ Therapeutics had 40 employees as of September 30, 2026. The number of employees decreased by 112 or 73.68% since the number was reported on December 31, 2025. That makes LENZ Therapeutics the 36,059th largest employer in the world and 4,878th in the United States.
Employees
40
Change
-112
Growth
-73.68%
Revenue / Employee
$308,975
Profits / Employee
-$3,506,775
Market Cap
129.77M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2026 | 40 | -112 | -73.68% |
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Codexis | 146 |
| Innate Pharma | 120 |
| Foghorn Therapeutics | 106 |
| PolyPid | 75 |
| Armata Pharmaceuticals | 61 |
| Jyong Biotech | 27 |
| Spruce Biosciences | 25 |
LENZ News
- 10 days ago - Lenz Therapeutics price target lowered to $9 from $10 at Citi - TheFly
- 16 days ago - Lenz Therapeutics price target lowered to $16 from $38 at H.C. Wainwright - TheFly
- 17 days ago - Lenz Therapeutics price target lowered to $45 from $50 at TD Cowen - TheFly
- 17 days ago - LENZ Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 17 days ago - LENZ Therapeutics Earnings release: Q3 2026 - Filings
- 17 days ago - LENZ Therapeutics Quarterly report: Q3 2026 - Filings
- 17 days ago - LENZ Therapeutics Slides: Q3 2026 - Filings
- 18 days ago - Lenz Therapeutics reports Q3 EPS (99c), consensus (95c) - TheFly